Fundraising FoxBrightstone Venture Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
ResistanceBioresistance.bioinSeed · Jan 2024Defunct
ResistanceBio develops treatments to address drug resistance in cancer patients.
BiotechHealthtechSan Francisco, US
Nicholas Goldner(CEO)inChristopher Bulow(Founder)inKYLE LAPHAM(Executive Officer, Director)
BoardOMRI AMIRAV-DRORY(Director)in
Co-investorsAlumni VenturesFifty YearsY CombinatorAsymmetry VenturesCantos VenturesCentennial Investors+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.